nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP2A6—Fluorouracil—colon cancer	0.131	0.171	CbGbCtD
Norfloxacin—CYP3A7—Irinotecan—colon cancer	0.0932	0.122	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0932	0.122	CbGbCtD
Norfloxacin—CYP3A7—Vincristine—colon cancer	0.0815	0.106	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0815	0.106	CbGbCtD
Norfloxacin—CYP3A5—Irinotecan—colon cancer	0.0699	0.0912	CbGbCtD
Norfloxacin—CYP3A5—Vincristine—colon cancer	0.0611	0.0797	CbGbCtD
Norfloxacin—SLC22A6—Methotrexate—colon cancer	0.0541	0.0705	CbGbCtD
Norfloxacin—CYP1A2—Fluorouracil—colon cancer	0.0499	0.0652	CbGbCtD
Norfloxacin—CYP3A4—Irinotecan—colon cancer	0.0273	0.0356	CbGbCtD
Norfloxacin—CYP3A4—Vincristine—colon cancer	0.0238	0.0311	CbGbCtD
Norfloxacin—TOP2A—Topotecan—Irinotecan—colon cancer	0.00313	0.404	CbGdCrCtD
Norfloxacin—TOP2A—Vindesine—Vincristine—colon cancer	0.00224	0.289	CbGdCrCtD
Norfloxacin—TOP2A—Vinorelbine—Vincristine—colon cancer	0.00141	0.182	CbGdCrCtD
Norfloxacin—TOP2A—Vinblastine—Vincristine—colon cancer	0.000972	0.125	CbGdCrCtD
Norfloxacin—Myocardial infarction—Irinotecan—colon cancer	0.000809	0.00359	CcSEcCtD
Norfloxacin—Jaundice—Irinotecan—colon cancer	0.000805	0.00357	CcSEcCtD
Norfloxacin—Stomatitis—Irinotecan—colon cancer	0.000805	0.00357	CcSEcCtD
Norfloxacin—Deafness—Capecitabine—colon cancer	0.000802	0.00355	CcSEcCtD
Norfloxacin—Hepatic failure—Capecitabine—colon cancer	0.000798	0.00354	CcSEcCtD
Norfloxacin—Haemolytic anaemia—Capecitabine—colon cancer	0.000794	0.00352	CcSEcCtD
Norfloxacin—Eye pain—Capecitabine—colon cancer	0.000794	0.00352	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Fluorouracil—colon cancer	0.00078	0.00346	CcSEcCtD
Norfloxacin—Dysarthria—Methotrexate—colon cancer	0.000778	0.00345	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Fluorouracil—colon cancer	0.000775	0.00344	CcSEcCtD
Norfloxacin—Myocardial infarction—Fluorouracil—colon cancer	0.000775	0.00344	CcSEcCtD
Norfloxacin—Stomatitis—Fluorouracil—colon cancer	0.000771	0.00342	CcSEcCtD
Norfloxacin—Conjunctivitis—Fluorouracil—colon cancer	0.000769	0.00341	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Capecitabine—colon cancer	0.00076	0.00337	CcSEcCtD
Norfloxacin—Hypoaesthesia—Vincristine—colon cancer	0.000757	0.00336	CcSEcCtD
Norfloxacin—Hallucination—Vincristine—colon cancer	0.000757	0.00336	CcSEcCtD
Norfloxacin—Vasculitis—Methotrexate—colon cancer	0.000754	0.00334	CcSEcCtD
Norfloxacin—Dermatitis bullous—Capecitabine—colon cancer	0.00075	0.00333	CcSEcCtD
Norfloxacin—Agranulocytosis—Fluorouracil—colon cancer	0.000738	0.00327	CcSEcCtD
Norfloxacin—Arthritis—Capecitabine—colon cancer	0.000738	0.00327	CcSEcCtD
Norfloxacin—Diplopia—Capecitabine—colon cancer	0.000717	0.00318	CcSEcCtD
Norfloxacin—Osteoarthritis—Capecitabine—colon cancer	0.000717	0.00318	CcSEcCtD
Norfloxacin—Visual impairment—Irinotecan—colon cancer	0.000714	0.00317	CcSEcCtD
Norfloxacin—Hypoaesthesia—Fluorouracil—colon cancer	0.000706	0.00313	CcSEcCtD
Norfloxacin—Irritability—Capecitabine—colon cancer	0.000685	0.00303	CcSEcCtD
Norfloxacin—Ataxia—Capecitabine—colon cancer	0.000674	0.00299	CcSEcCtD
Norfloxacin—Blood creatinine increased—Capecitabine—colon cancer	0.000672	0.00298	CcSEcCtD
Norfloxacin—Chills—Irinotecan—colon cancer	0.000665	0.00295	CcSEcCtD
Norfloxacin—Mouth ulceration—Methotrexate—colon cancer	0.000665	0.00295	CcSEcCtD
Norfloxacin—Liver function test abnormal—Capecitabine—colon cancer	0.000662	0.00293	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Capecitabine—colon cancer	0.000655	0.0029	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000646	0.00286	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000646	0.00286	CcSEcCtD
Norfloxacin—Back pain—Vincristine—colon cancer	0.000641	0.00284	CcSEcCtD
Norfloxacin—Flatulence—Irinotecan—colon cancer	0.000636	0.00282	CcSEcCtD
Norfloxacin—Back pain—Irinotecan—colon cancer	0.000624	0.00277	CcSEcCtD
Norfloxacin—Muscle spasms—Irinotecan—colon cancer	0.00062	0.00275	CcSEcCtD
Norfloxacin—Dysphagia—Capecitabine—colon cancer	0.00062	0.00275	CcSEcCtD
Norfloxacin—Erythema—Fluorouracil—colon cancer	0.000618	0.00274	CcSEcCtD
Norfloxacin—Agitation—Vincristine—colon cancer	0.000609	0.0027	CcSEcCtD
Norfloxacin—Photosensitivity—Methotrexate—colon cancer	0.000608	0.0027	CcSEcCtD
Norfloxacin—Vertigo—Vincristine—colon cancer	0.000595	0.00264	CcSEcCtD
Norfloxacin—Hepatic failure—Methotrexate—colon cancer	0.000594	0.00263	CcSEcCtD
Norfloxacin—Leukopenia—Vincristine—colon cancer	0.000593	0.00263	CcSEcCtD
Norfloxacin—Vision blurred—Fluorouracil—colon cancer	0.000582	0.00258	CcSEcCtD
Norfloxacin—Vertigo—Irinotecan—colon cancer	0.00058	0.00257	CcSEcCtD
Norfloxacin—Neutropenia—Capecitabine—colon cancer	0.00058	0.00257	CcSEcCtD
Norfloxacin—Leukopenia—Irinotecan—colon cancer	0.000578	0.00256	CcSEcCtD
Norfloxacin—Convulsion—Vincristine—colon cancer	0.000574	0.00254	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Methotrexate—colon cancer	0.000566	0.00251	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Capecitabine—colon cancer	0.000566	0.00251	CcSEcCtD
Norfloxacin—Myalgia—Vincristine—colon cancer	0.000564	0.0025	CcSEcCtD
Norfloxacin—Visual disturbance—Methotrexate—colon cancer	0.000563	0.0025	CcSEcCtD
Norfloxacin—Leukopenia—Fluorouracil—colon cancer	0.000553	0.00245	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Methotrexate—colon cancer	0.000552	0.00245	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000548	0.00243	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Capecitabine—colon cancer	0.000545	0.00241	CcSEcCtD
Norfloxacin—Renal failure—Capecitabine—colon cancer	0.000543	0.00241	CcSEcCtD
Norfloxacin—Myocardial infarction—Capecitabine—colon cancer	0.000542	0.0024	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Capecitabine—colon cancer	0.000542	0.0024	CcSEcCtD
Norfloxacin—Oedema—Vincristine—colon cancer	0.000541	0.0024	CcSEcCtD
Norfloxacin—Anaphylactic shock—Vincristine—colon cancer	0.000541	0.0024	CcSEcCtD
Norfloxacin—Stomatitis—Capecitabine—colon cancer	0.000539	0.00239	CcSEcCtD
Norfloxacin—Jaundice—Capecitabine—colon cancer	0.000539	0.00239	CcSEcCtD
Norfloxacin—Conjunctivitis—Capecitabine—colon cancer	0.000537	0.00238	CcSEcCtD
Norfloxacin—Convulsion—Fluorouracil—colon cancer	0.000536	0.00237	CcSEcCtD
Norfloxacin—Osteoarthritis—Methotrexate—colon cancer	0.000534	0.00237	CcSEcCtD
Norfloxacin—Confusional state—Irinotecan—colon cancer	0.000531	0.00235	CcSEcCtD
Norfloxacin—Thrombocytopenia—Vincristine—colon cancer	0.00053	0.00235	CcSEcCtD
Norfloxacin—Haematuria—Capecitabine—colon cancer	0.000527	0.00234	CcSEcCtD
Norfloxacin—Oedema—Irinotecan—colon cancer	0.000527	0.00233	CcSEcCtD
Norfloxacin—Anaphylactic shock—Irinotecan—colon cancer	0.000527	0.00233	CcSEcCtD
Norfloxacin—Chest pain—Fluorouracil—colon cancer	0.000526	0.00233	CcSEcCtD
Norfloxacin—Myalgia—Fluorouracil—colon cancer	0.000526	0.00233	CcSEcCtD
Norfloxacin—Hyperhidrosis—Vincristine—colon cancer	0.000523	0.00232	CcSEcCtD
Norfloxacin—Agranulocytosis—Capecitabine—colon cancer	0.000516	0.00229	CcSEcCtD
Norfloxacin—Thrombocytopenia—Irinotecan—colon cancer	0.000516	0.00229	CcSEcCtD
Norfloxacin—Anorexia—Vincristine—colon cancer	0.000515	0.00228	CcSEcCtD
Norfloxacin—Irritability—Methotrexate—colon cancer	0.00051	0.00226	CcSEcCtD
Norfloxacin—Hyperhidrosis—Irinotecan—colon cancer	0.000509	0.00226	CcSEcCtD
Norfloxacin—Confusional state—Fluorouracil—colon cancer	0.000509	0.00225	CcSEcCtD
Norfloxacin—Anaphylactic shock—Fluorouracil—colon cancer	0.000504	0.00224	CcSEcCtD
Norfloxacin—Oedema—Fluorouracil—colon cancer	0.000504	0.00224	CcSEcCtD
Norfloxacin—Anorexia—Irinotecan—colon cancer	0.000502	0.00223	CcSEcCtD
Norfloxacin—Ataxia—Methotrexate—colon cancer	0.000502	0.00223	CcSEcCtD
Norfloxacin—Hepatitis—Capecitabine—colon cancer	0.000496	0.0022	CcSEcCtD
Norfloxacin—Thrombocytopenia—Fluorouracil—colon cancer	0.000494	0.00219	CcSEcCtD
Norfloxacin—Hypoaesthesia—Capecitabine—colon cancer	0.000494	0.00219	CcSEcCtD
Norfloxacin—Liver function test abnormal—Methotrexate—colon cancer	0.000493	0.00218	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000493	0.00218	CcSEcCtD
Norfloxacin—Insomnia—Vincristine—colon cancer	0.000489	0.00217	CcSEcCtD
Norfloxacin—Paraesthesia—Vincristine—colon cancer	0.000486	0.00215	CcSEcCtD
Norfloxacin—Anorexia—Fluorouracil—colon cancer	0.000481	0.00213	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000481	0.00213	CcSEcCtD
Norfloxacin—Visual impairment—Capecitabine—colon cancer	0.000478	0.00212	CcSEcCtD
Norfloxacin—Insomnia—Irinotecan—colon cancer	0.000476	0.00211	CcSEcCtD
Norfloxacin—Paraesthesia—Irinotecan—colon cancer	0.000473	0.0021	CcSEcCtD
Norfloxacin—Decreased appetite—Vincristine—colon cancer	0.00047	0.00208	CcSEcCtD
Norfloxacin—Dyspnoea—Irinotecan—colon cancer	0.00047	0.00208	CcSEcCtD
Norfloxacin—Erythema multiforme—Capecitabine—colon cancer	0.000469	0.00208	CcSEcCtD
Norfloxacin—Somnolence—Irinotecan—colon cancer	0.000468	0.00208	CcSEcCtD
Norfloxacin—Fatigue—Vincristine—colon cancer	0.000466	0.00207	CcSEcCtD
Norfloxacin—Dyspepsia—Irinotecan—colon cancer	0.000464	0.00205	CcSEcCtD
Norfloxacin—Tinnitus—Capecitabine—colon cancer	0.000463	0.00205	CcSEcCtD
Norfloxacin—Constipation—Vincristine—colon cancer	0.000462	0.00205	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00046	0.00204	CcSEcCtD
Norfloxacin—Decreased appetite—Irinotecan—colon cancer	0.000458	0.00203	CcSEcCtD
Norfloxacin—Eosinophilia—Methotrexate—colon cancer	0.000457	0.00203	CcSEcCtD
Norfloxacin—Insomnia—Fluorouracil—colon cancer	0.000456	0.00202	CcSEcCtD
Norfloxacin—Fatigue—Irinotecan—colon cancer	0.000454	0.00201	CcSEcCtD
Norfloxacin—Paraesthesia—Fluorouracil—colon cancer	0.000453	0.00201	CcSEcCtD
Norfloxacin—Pancreatitis—Methotrexate—colon cancer	0.000452	0.00201	CcSEcCtD
Norfloxacin—Constipation—Irinotecan—colon cancer	0.00045	0.002	CcSEcCtD
Norfloxacin—Dyspnoea—Fluorouracil—colon cancer	0.00045	0.00199	CcSEcCtD
Norfloxacin—Somnolence—Fluorouracil—colon cancer	0.000448	0.00199	CcSEcCtD
Norfloxacin—Chills—Capecitabine—colon cancer	0.000445	0.00197	CcSEcCtD
Norfloxacin—Dyspepsia—Fluorouracil—colon cancer	0.000444	0.00197	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Vincristine—colon cancer	0.000442	0.00196	CcSEcCtD
Norfloxacin—Decreased appetite—Fluorouracil—colon cancer	0.000438	0.00194	CcSEcCtD
Norfloxacin—Feeling abnormal—Irinotecan—colon cancer	0.000434	0.00192	CcSEcCtD
Norfloxacin—Erythema—Capecitabine—colon cancer	0.000432	0.00191	CcSEcCtD
Norfloxacin—Neutropenia—Methotrexate—colon cancer	0.000431	0.00191	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Irinotecan—colon cancer	0.000431	0.00191	CcSEcCtD
Norfloxacin—Body temperature increased—Vincristine—colon cancer	0.000428	0.00189	CcSEcCtD
Norfloxacin—Abdominal pain—Vincristine—colon cancer	0.000428	0.00189	CcSEcCtD
Norfloxacin—Flatulence—Capecitabine—colon cancer	0.000426	0.00189	CcSEcCtD
Norfloxacin—Dysgeusia—Capecitabine—colon cancer	0.000423	0.00187	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Methotrexate—colon cancer	0.000421	0.00187	CcSEcCtD
Norfloxacin—Back pain—Capecitabine—colon cancer	0.000418	0.00185	CcSEcCtD
Norfloxacin—Body temperature increased—Irinotecan—colon cancer	0.000416	0.00185	CcSEcCtD
Norfloxacin—Abdominal pain—Irinotecan—colon cancer	0.000416	0.00185	CcSEcCtD
Norfloxacin—Feeling abnormal—Fluorouracil—colon cancer	0.000416	0.00184	CcSEcCtD
Norfloxacin—Muscle spasms—Capecitabine—colon cancer	0.000415	0.00184	CcSEcCtD
Norfloxacin—Drowsiness—Methotrexate—colon cancer	0.000411	0.00182	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000408	0.00181	CcSEcCtD
Norfloxacin—Vision blurred—Capecitabine—colon cancer	0.000407	0.0018	CcSEcCtD
Norfloxacin—Tremor—Capecitabine—colon cancer	0.000405	0.00179	CcSEcCtD
Norfloxacin—Renal failure—Methotrexate—colon cancer	0.000404	0.00179	CcSEcCtD
Norfloxacin—Stomatitis—Methotrexate—colon cancer	0.000401	0.00178	CcSEcCtD
Norfloxacin—Urticaria—Fluorouracil—colon cancer	0.000401	0.00178	CcSEcCtD
Norfloxacin—Conjunctivitis—Methotrexate—colon cancer	0.0004	0.00177	CcSEcCtD
Norfloxacin—Body temperature increased—Fluorouracil—colon cancer	0.000399	0.00177	CcSEcCtD
Norfloxacin—Hypersensitivity—Vincristine—colon cancer	0.000398	0.00177	CcSEcCtD
Norfloxacin—Haematuria—Methotrexate—colon cancer	0.000392	0.00174	CcSEcCtD
Norfloxacin—Vertigo—Capecitabine—colon cancer	0.000388	0.00172	CcSEcCtD
Norfloxacin—Hypersensitivity—Irinotecan—colon cancer	0.000388	0.00172	CcSEcCtD
Norfloxacin—Asthenia—Vincristine—colon cancer	0.000388	0.00172	CcSEcCtD
Norfloxacin—Leukopenia—Capecitabine—colon cancer	0.000387	0.00171	CcSEcCtD
Norfloxacin—Agranulocytosis—Methotrexate—colon cancer	0.000384	0.0017	CcSEcCtD
Norfloxacin—Palpitations—Capecitabine—colon cancer	0.000382	0.00169	CcSEcCtD
Norfloxacin—Asthenia—Irinotecan—colon cancer	0.000378	0.00167	CcSEcCtD
Norfloxacin—Hypersensitivity—Fluorouracil—colon cancer	0.000372	0.00165	CcSEcCtD
Norfloxacin—Diarrhoea—Vincristine—colon cancer	0.00037	0.00164	CcSEcCtD
Norfloxacin—Hepatitis—Methotrexate—colon cancer	0.000369	0.00164	CcSEcCtD
Norfloxacin—Arthralgia—Capecitabine—colon cancer	0.000368	0.00163	CcSEcCtD
Norfloxacin—Chest pain—Capecitabine—colon cancer	0.000368	0.00163	CcSEcCtD
Norfloxacin—Myalgia—Capecitabine—colon cancer	0.000368	0.00163	CcSEcCtD
Norfloxacin—Anxiety—Capecitabine—colon cancer	0.000366	0.00162	CcSEcCtD
Norfloxacin—Diarrhoea—Irinotecan—colon cancer	0.00036	0.0016	CcSEcCtD
Norfloxacin—Dry mouth—Capecitabine—colon cancer	0.00036	0.00159	CcSEcCtD
Norfloxacin—Dizziness—Vincristine—colon cancer	0.000358	0.00159	CcSEcCtD
Norfloxacin—Pruritus—Fluorouracil—colon cancer	0.000357	0.00158	CcSEcCtD
Norfloxacin—Visual impairment—Methotrexate—colon cancer	0.000356	0.00158	CcSEcCtD
Norfloxacin—Confusional state—Capecitabine—colon cancer	0.000355	0.00158	CcSEcCtD
Norfloxacin—Oedema—Capecitabine—colon cancer	0.000352	0.00156	CcSEcCtD
Norfloxacin—Erythema multiforme—Methotrexate—colon cancer	0.000349	0.00155	CcSEcCtD
Norfloxacin—Dizziness—Irinotecan—colon cancer	0.000348	0.00154	CcSEcCtD
Norfloxacin—Diarrhoea—Fluorouracil—colon cancer	0.000345	0.00153	CcSEcCtD
Norfloxacin—Thrombocytopenia—Capecitabine—colon cancer	0.000345	0.00153	CcSEcCtD
Norfloxacin—Tinnitus—Methotrexate—colon cancer	0.000344	0.00153	CcSEcCtD
Norfloxacin—Vomiting—Vincristine—colon cancer	0.000344	0.00152	CcSEcCtD
Norfloxacin—Rash—Vincristine—colon cancer	0.000341	0.00151	CcSEcCtD
Norfloxacin—Hyperhidrosis—Capecitabine—colon cancer	0.000341	0.00151	CcSEcCtD
Norfloxacin—Dermatitis—Vincristine—colon cancer	0.000341	0.00151	CcSEcCtD
Norfloxacin—Headache—Vincristine—colon cancer	0.000339	0.0015	CcSEcCtD
Norfloxacin—Anorexia—Capecitabine—colon cancer	0.000336	0.00149	CcSEcCtD
Norfloxacin—Vomiting—Irinotecan—colon cancer	0.000335	0.00148	CcSEcCtD
Norfloxacin—Dizziness—Fluorouracil—colon cancer	0.000334	0.00148	CcSEcCtD
Norfloxacin—Rash—Irinotecan—colon cancer	0.000332	0.00147	CcSEcCtD
Norfloxacin—Dermatitis—Irinotecan—colon cancer	0.000332	0.00147	CcSEcCtD
Norfloxacin—Chills—Methotrexate—colon cancer	0.000331	0.00147	CcSEcCtD
Norfloxacin—Headache—Irinotecan—colon cancer	0.00033	0.00146	CcSEcCtD
Norfloxacin—Erythema—Methotrexate—colon cancer	0.000322	0.00143	CcSEcCtD
Norfloxacin—Nausea—Vincristine—colon cancer	0.000321	0.00142	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000321	0.00142	CcSEcCtD
Norfloxacin—Vomiting—Fluorouracil—colon cancer	0.000321	0.00142	CcSEcCtD
Norfloxacin—Insomnia—Capecitabine—colon cancer	0.000319	0.00141	CcSEcCtD
Norfloxacin—Rash—Fluorouracil—colon cancer	0.000318	0.00141	CcSEcCtD
Norfloxacin—Dermatitis—Fluorouracil—colon cancer	0.000318	0.00141	CcSEcCtD
Norfloxacin—Paraesthesia—Capecitabine—colon cancer	0.000317	0.0014	CcSEcCtD
Norfloxacin—Headache—Fluorouracil—colon cancer	0.000316	0.0014	CcSEcCtD
Norfloxacin—Dysgeusia—Methotrexate—colon cancer	0.000315	0.0014	CcSEcCtD
Norfloxacin—Dyspnoea—Capecitabine—colon cancer	0.000314	0.00139	CcSEcCtD
Norfloxacin—Nausea—Irinotecan—colon cancer	0.000313	0.00139	CcSEcCtD
Norfloxacin—Back pain—Methotrexate—colon cancer	0.000311	0.00138	CcSEcCtD
Norfloxacin—Dyspepsia—Capecitabine—colon cancer	0.00031	0.00138	CcSEcCtD
Norfloxacin—Decreased appetite—Capecitabine—colon cancer	0.000306	0.00136	CcSEcCtD
Norfloxacin—Fatigue—Capecitabine—colon cancer	0.000304	0.00135	CcSEcCtD
Norfloxacin—Vision blurred—Methotrexate—colon cancer	0.000303	0.00134	CcSEcCtD
Norfloxacin—Constipation—Capecitabine—colon cancer	0.000301	0.00134	CcSEcCtD
Norfloxacin—Nausea—Fluorouracil—colon cancer	0.0003	0.00133	CcSEcCtD
Norfloxacin—Feeling abnormal—Capecitabine—colon cancer	0.00029	0.00129	CcSEcCtD
Norfloxacin—Vertigo—Methotrexate—colon cancer	0.000289	0.00128	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Capecitabine—colon cancer	0.000288	0.00128	CcSEcCtD
Norfloxacin—Leukopenia—Methotrexate—colon cancer	0.000288	0.00128	CcSEcCtD
Norfloxacin—Urticaria—Capecitabine—colon cancer	0.00028	0.00124	CcSEcCtD
Norfloxacin—Body temperature increased—Capecitabine—colon cancer	0.000279	0.00124	CcSEcCtD
Norfloxacin—Abdominal pain—Capecitabine—colon cancer	0.000279	0.00124	CcSEcCtD
Norfloxacin—Convulsion—Methotrexate—colon cancer	0.000279	0.00123	CcSEcCtD
Norfloxacin—Arthralgia—Methotrexate—colon cancer	0.000274	0.00121	CcSEcCtD
Norfloxacin—Myalgia—Methotrexate—colon cancer	0.000274	0.00121	CcSEcCtD
Norfloxacin—Chest pain—Methotrexate—colon cancer	0.000274	0.00121	CcSEcCtD
Norfloxacin—Confusional state—Methotrexate—colon cancer	0.000265	0.00117	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methotrexate—colon cancer	0.000262	0.00116	CcSEcCtD
Norfloxacin—Hypersensitivity—Capecitabine—colon cancer	0.00026	0.00115	CcSEcCtD
Norfloxacin—Thrombocytopenia—Methotrexate—colon cancer	0.000257	0.00114	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methotrexate—colon cancer	0.000254	0.00112	CcSEcCtD
Norfloxacin—Asthenia—Capecitabine—colon cancer	0.000253	0.00112	CcSEcCtD
Norfloxacin—Anorexia—Methotrexate—colon cancer	0.00025	0.00111	CcSEcCtD
Norfloxacin—Pruritus—Capecitabine—colon cancer	0.000249	0.00111	CcSEcCtD
Norfloxacin—Diarrhoea—Capecitabine—colon cancer	0.000241	0.00107	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000239	0.00106	CcSEcCtD
Norfloxacin—Insomnia—Methotrexate—colon cancer	0.000237	0.00105	CcSEcCtD
Norfloxacin—Paraesthesia—Methotrexate—colon cancer	0.000236	0.00104	CcSEcCtD
Norfloxacin—Dyspnoea—Methotrexate—colon cancer	0.000234	0.00104	CcSEcCtD
Norfloxacin—Somnolence—Methotrexate—colon cancer	0.000233	0.00103	CcSEcCtD
Norfloxacin—Dizziness—Capecitabine—colon cancer	0.000233	0.00103	CcSEcCtD
Norfloxacin—Dyspepsia—Methotrexate—colon cancer	0.000231	0.00102	CcSEcCtD
Norfloxacin—Decreased appetite—Methotrexate—colon cancer	0.000228	0.00101	CcSEcCtD
Norfloxacin—Fatigue—Methotrexate—colon cancer	0.000226	0.001	CcSEcCtD
Norfloxacin—Vomiting—Capecitabine—colon cancer	0.000224	0.000993	CcSEcCtD
Norfloxacin—Rash—Capecitabine—colon cancer	0.000222	0.000985	CcSEcCtD
Norfloxacin—Dermatitis—Capecitabine—colon cancer	0.000222	0.000984	CcSEcCtD
Norfloxacin—Headache—Capecitabine—colon cancer	0.000221	0.000979	CcSEcCtD
Norfloxacin—Feeling abnormal—Methotrexate—colon cancer	0.000216	0.000958	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methotrexate—colon cancer	0.000215	0.000951	CcSEcCtD
Norfloxacin—Nausea—Capecitabine—colon cancer	0.000209	0.000928	CcSEcCtD
Norfloxacin—Urticaria—Methotrexate—colon cancer	0.000208	0.000924	CcSEcCtD
Norfloxacin—Body temperature increased—Methotrexate—colon cancer	0.000207	0.000919	CcSEcCtD
Norfloxacin—Abdominal pain—Methotrexate—colon cancer	0.000207	0.000919	CcSEcCtD
Norfloxacin—Hypersensitivity—Methotrexate—colon cancer	0.000193	0.000857	CcSEcCtD
Norfloxacin—Asthenia—Methotrexate—colon cancer	0.000188	0.000835	CcSEcCtD
Norfloxacin—Pruritus—Methotrexate—colon cancer	0.000186	0.000823	CcSEcCtD
Norfloxacin—Diarrhoea—Methotrexate—colon cancer	0.00018	0.000796	CcSEcCtD
Norfloxacin—Dizziness—Methotrexate—colon cancer	0.000174	0.000769	CcSEcCtD
Norfloxacin—Vomiting—Methotrexate—colon cancer	0.000167	0.00074	CcSEcCtD
Norfloxacin—Rash—Methotrexate—colon cancer	0.000165	0.000733	CcSEcCtD
Norfloxacin—Dermatitis—Methotrexate—colon cancer	0.000165	0.000733	CcSEcCtD
Norfloxacin—Headache—Methotrexate—colon cancer	0.000164	0.000729	CcSEcCtD
Norfloxacin—Nausea—Methotrexate—colon cancer	0.000156	0.000691	CcSEcCtD
Norfloxacin—Levofloxacin—ABCB1—colon cancer	0.00011	0.509	CrCbGaD
Norfloxacin—Ciprofloxacin—ABCB1—colon cancer	0.000106	0.491	CrCbGaD
